| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2010.32.6223 |
| P698 | PubMed publication ID | 21670463 |
| P50 | author | David E. Fisher | Q90306386 |
| P2093 | author name string | Rizwan Haq | |
| P433 | issue | 25 | |
| P304 | page(s) | 3474-3482 | |
| P577 | publication date | 2011-06-13 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer | |
| P478 | volume | 29 |
| Q34781474 | A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression |
| Q36978081 | BPTF transduces MITF-driven prosurvival signals in melanoma cells |
| Q37676779 | Cathepsin K in the immunohistochemical diagnosis of melanocytic lesions |
| Q46447458 | Change is in the air: the hypoxic induction of phenotype switching in melanoma |
| Q39216584 | Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein |
| Q47614399 | Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome. |
| Q36998897 | Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells |
| Q35606985 | Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications |
| Q35000629 | E2F4 regulatory program predicts patient survival prognosis in breast cancer |
| Q33907259 | Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases |
| Q27332453 | Genetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in mice |
| Q38922877 | Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells |
| Q64978186 | How anti-PD1 treatments are changing the management of melanoma. |
| Q36998335 | Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma |
| Q39197388 | Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. |
| Q35499428 | Inhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma |
| Q91747205 | Lysosomal size matters |
| Q37705148 | MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors |
| Q35062693 | MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. |
| Q35187734 | MITF in melanoma: mechanisms behind its expression and activity. |
| Q92534457 | MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat |
| Q34371874 | Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report. |
| Q90043581 | Melanoma Metabolism: Cell Survival and Resistance to Therapy |
| Q28069081 | Metabolic rewiring in melanoma |
| Q33560698 | Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation |
| Q34206517 | Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes |
| Q64073423 | Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis |
| Q36793719 | Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. |
| Q53823687 | Overexpression of TFEB Drives a Pleiotropic Neurotrophic Effect and Prevents Parkinson's Disease-Related Neurodegeneration. |
| Q40954944 | PEComa with Transcription Factor E3 Overexpression: A Diagnostic and Therapeutic Challenge |
| Q26780372 | Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up |
| Q85345511 | Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features |
| Q42543783 | Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction |
| Q92887097 | Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients |
| Q38241749 | Pro-survival role of MITF in melanoma |
| Q47134263 | Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma |
| Q37208207 | Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases |
| Q34342483 | Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB |
| Q35810625 | Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes |
| Q38864381 | TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress |
| Q61812478 | TFEB controls vascular development by regulating the proliferation of endothelial cells |
| Q95326317 | TFEB regulates murine liver cell fate during development and regeneration |
| Q92931986 | TFEB-mTORC1 feedback loop in metabolism and cancer |
| Q100526333 | Targetable gene fusions and aberrations in genitourinary oncology |
| Q26824642 | Targeting melanoma by small molecules: challenges ahead |
| Q63383614 | The complex relationship between TFEB transcription factor phosphorylation and subcellular localization |
| Q37507876 | The impact of MITF on melanoma development: news from bench and bedside |
| Q30524831 | The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis |
| Q91942557 | Transcriptional Regulation of Autophagy: Mechanisms and Diseases |
| Q46988918 | Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth |
| Q37378754 | Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism |
| Q60919960 | Transcriptional regulation of mTORC1 in cancer |
| Q37024596 | Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3. |
| Q39158551 | Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement. |
| Q38656012 | Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer |
| Q34062540 | piggyBac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice |
Search more.